- Clinical and biological prognostic factors in follicular lymphoma ...🔍
- Predicting High|Risk Disease Using Progression of Disease in 24 ...🔍
- Predicting and Analyzing Response in Follicular Lymphoma🔍
- Prognostic factors and risk of transformation in marginal zone ...🔍
- Follicular Lymphoma🔍
- Analysis of prognostic and risk factors during the early relapse ...🔍
- Predicting early progression in follicular lymphoma🔍
- Tisa|cel Offers Durable Responses in R/R Follicular Lymphoma🔍
Clinical Factors that Predict POD24
Clinical and biological prognostic factors in follicular lymphoma ...
POD24 was detected in 32 patients. We identified 114 accessible staging PET/CT scans, of which 64 had an interim and 80 had a restaging scan.
Predicting High-Risk Disease Using Progression of Disease in 24 ...
... clinical outcomes, including reduced survival, when FL patients are ... Predicting High-Risk Disease Using Progression of Disease in 24 Months (POD24) ...
Predicting and Analyzing Response in Follicular Lymphoma - OncLive
We confirmed the CT-based POD24 or PFS24 is still prognostically significant, predicts a worse outcome. But if you use a PET scan, this ...
Prognostic factors and risk of transformation in marginal zone ...
... patients without POD24. Conconi et al. also ... In summary, clinical prognostic indexes were developed to predict outcome of patients with EMZL and SMZL.
Follicular Lymphoma: Refining Prognostic Models and Impact of Pod ...
Several models incorporating clinical laboratory variables ... Evaluation of the different stratification models for POD24 prediction in patients ...
Analysis of prognostic and risk factors during the early relapse ...
Logistic analysis was performed to identify the risk factors associated with POD24. Results: Among the 140 patients newly diagnosed with FL, 42 (30%) patients ...
Predicting early progression in follicular lymphoma - Semantic Scholar
The existing and emerging risk-stratification tools, based on clinical, molecular and imaging attributes, are described, and their ability ...
Tisa-cel Offers Durable Responses in R/R Follicular Lymphoma
We call that POD24, or progression of disease within 24 months. More than two-thirds of the patients on this trial had progression of disease ...
How I treat high risk Follicular Lymphoma Wolfgang Hiddemann, MD ...
• are primarily based on clinical factors. • are not specific enough for ... How to treat patients with POD 24? Page 13. Early Progression of Disease ...
Prospects in the management of patients with follicular lymphoma ...
These findings have led some to advocate for more intensive therapy (such as autologous stem cell transplant – ASCT) in patients with POD24 ...
Follicular Lymphoma: Refining Prognostic Models and Impact of Pod ...
Several models incorporating clinical laboratory variables and molecular biomarkers are able to predict its prognosis, allowing to stratify patients into ...
Relapsed Follicular Lymphoma With POD 24 - The ASCO Post
In the conversation that follows, the faculty discuss the meaning and clinical implication of POD-24, optimal treatment options for patients who ...
A new prognostic model is proposed for follicular lymphoma
Predicting disease progression · Sensitivity and specificity for a FLEX high-risk score to predict POD24 were 60% and 68%, respectively. · By ...
POD24 in follicular lymphoma - a questionable outcome
... clinical trials. Beyond risk prediction, they are also interested in “risk stratifying” patients to guide patient selection in clinical ...
Machine learning models predict overall survival and progression ...
[17] combined CT radiomics features and clinical risk factors to determine recurrence-free survival (RFS) and OS after surgery in patients with ...